Literature DB >> 1458484

Consistent disruption of the AML1 gene occurs within a single intron in the t(8;21) chromosomal translocation.

K Shimizu1, H Miyoshi, T Kozu, J Nagata, K Enomoto, N Maseki, Y Kaneko, M Ohki.   

Abstract

The AML1 gene on chromosome 21 was rearranged by the t(8;21) chromosomal translocation in acute myeloid leukemia (AML). Southern blot analysis of 21 AML patients with t(8;21), including three with complex translocations, t(8;V;21), demonstrated that all the breakpoints occurred at random within a single intron between two coding exons of AML1. Clustering of the breakpoints in the restricted intron suggests the formation of a unique fusion gene between the AML1 gene and a presumable counterpart gene on chromosome 8. Nucleotide sequencing of the breakpoint region revealed that the translocation event was accompanied by deletion of a short stretch of nucleotides.

Entities:  

Mesh:

Year:  1992        PMID: 1458484

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  14 in total

Review 1.  AML1-ETO driven acute leukemia: insights into pathogenesis and potential therapeutic approaches.

Authors:  Megan A Hatlen; Lan Wang; Stephen D Nimer
Journal:  Front Med       Date:  2012-08-09       Impact factor: 4.592

2.  A simple centrifugation method for harvesting myeloblasts.

Authors:  K Ogata
Journal:  Int J Hematol       Date:  2001-10       Impact factor: 2.490

3.  Alternative splicing and genomic structure of the AML1 gene involved in acute myeloid leukemia.

Authors:  H Miyoshi; M Ohira; K Shimizu; K Mitani; H Hirai; T Imai; K Yokoyama; E Soeda; M Ohki
Journal:  Nucleic Acids Res       Date:  1995-07-25       Impact factor: 16.971

4.  Genomic DNA breakpoints in AML1/RUNX1 and ETO cluster with topoisomerase II DNA cleavage and DNase I hypersensitive sites in t(8;21) leukemia.

Authors:  Yanming Zhang; Pamela Strissel; Reiner Strick; Jianjun Chen; Giuseppina Nucifora; Michelle M Le Beau; Richard A Larson; Janet D Rowley
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-26       Impact factor: 11.205

5.  AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation.

Authors:  T Miyamoto; I L Weissman; K Akashi
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

6.  Recurrence of acute myelogenous leukemia with the same AML1/ETO breakpoint as at diagnosis after complete remission lasting 15 years: analysis of stored bone marrow smears.

Authors:  Norifumi Tsukamoto; Masamitsu Karasawa; Yoko Tanaka; Akihiko Yokohama; Hideki Uchiumi; Takafumi Matsushima; Hirokazu Murakami; Yoshihisa Nojima
Journal:  Int J Hematol       Date:  2003-11       Impact factor: 2.490

7.  PEBP2 alpha B/mouse AML1 consists of multiple isoforms that possess differential transactivation potentials.

Authors:  S C Bae; E Ogawa; M Maruyama; H Oka; M Satake; K Shigesada; N A Jenkins; D J Gilbert; N G Copeland; Y Ito
Journal:  Mol Cell Biol       Date:  1994-05       Impact factor: 4.272

8.  An ets-related gene, ERG, is rearranged in human myeloid leukemia with t(16;21) chromosomal translocation.

Authors:  K Shimizu; H Ichikawa; A Tojo; Y Kaneko; N Maseki; Y Hayashi; M Ohira; S Asano; M Ohki
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

9.  Identification of AML1-ETO modulators by chemical genomics.

Authors:  Steven M Corsello; Giovanni Roti; Kenneth N Ross; Kwan T Chow; Ilene Galinsky; Daniel J DeAngelo; Richard M Stone; Andrew L Kung; Todd R Golub; Kimberly Stegmaier
Journal:  Blood       Date:  2009-04-17       Impact factor: 22.113

10.  Identification of AML-1 and the (8;21) translocation protein (AML-1/ETO) as sequence-specific DNA-binding proteins: the runt homology domain is required for DNA binding and protein-protein interactions.

Authors:  S Meyers; J R Downing; S W Hiebert
Journal:  Mol Cell Biol       Date:  1993-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.